2025 NIDA International Forum: Research Poster Abstract Submission and Travel Award Requests

Join the National Institute on Drug Abuse (NIDA) International Program for the 2025 NIDA International Forum, which will be held June 13–14, 2025, at the Sheraton New Orleans Hotel in New Orleans, Louisiana, USA.

The Forum research symposium, poster session, and network-building activities focus on the range and quality of drug use and addiction research conducted around the world. Participants meet talented colleagues and learn about drug use and addiction research and policy issues in other countries, as well as the NIDA-supported fellowships and other programs that can support international collaborations. There is no fee to attend the NIDA International Forum.

The NIDA International Program invites abstract submissions and travel award applications from researchers around the world. Join us for the in-person Forum research symposium, interactive workshops, poster session, and networking activities. 

Abstract Submission

Scientific research poster abstract submissions are now being accepted. Abstract submissions should:

• Be a topic relevant to NIDA International Research Priorities.
• Focus on international research, either conducted entirely in another country or by a multinational team working in another country.
• Include a concise statement of research and be structured in four labeled parts: 1) Background, 2) Methods, 3) Results, and 4) Conclusion.
• Not exceed 250 words.
• Be categorized with one of the following research topic areas:
  • Basic Science – Includes fields such as biochemistry, behavioral and biomedical neuroscience, microbiology, physiology, or pharmacology; laboratory studies with cell cultures, animals, or physiological experiments; genetic studies; and imaging studies.
  • Epidemiology – Studies that identify or examine the impact of individual, familial, behavioral, developmental, or socio-cultural/environmental risk and protective factors related to substance use and addiction.
  • Prevention – Studies that explore the development, testing, and translation of prevention interventions that target the initiation of drug use, progression to misuse and dependence, and transmission of HIV infection among diverse populations and settings.
  • Treatment – Studies on the development, implementation, and evaluation of behavioral, pharmacological, or integrated treatment interventions, including outcome and performance measures and treatment interventions targeted to under-resourced populations.
  • Informational – Reports on capacity-building programs, educational opportunities, international guidelines for collaboration, and drug policy development.
• Abstracts that focus ONLY on alcohol will NOT be accepted.